Extracorporeal life support in patients with severe trauma: An advanced treatment strategy for refractory clinical settings  Massimo Bonacchi, MD, Rosario.

Slides:



Advertisements
Similar presentations
Blood lactate level during extracorporeal life support as a surrogate marker for survival  Sung Jun Park, MD, Sang-pil Kim, MD, PhD, Joon Bum Kim, MD,
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Stephen R. Broderick, MD, MPHS 
Chetan Pasrija, MD, Michael A. Mazzeffi, MD, MPH, Zachary N. Kon, MD 
Extracorporeal membrane oxygenation for septic shock: Heroic futility?
Prediction of recurrent coarctation by early postoperative blood pressure gradient  T. K. Susheel Kumar, MD, David Zurakowski, PhD, Rishika Sharma, MD,
Prediction of severe acute kidney injury after pediatric cardiac surgery with the use of novel biomarkers: A new trend in clinical research and risk stratification 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Alan P. Kypson, MD, David W. Frazier, MD, Jon F. Moran, MD 
A novel strategy to improve systemic oxygenation in venovenous extracorporeal membrane oxygenation: The “χ-configuration”  Massimo Bonacchi, MD, Guy Harmelin,
Ludhmila A. Hajjar, MD, PhD, Juliano P. Almeida, MD, Julia T
Ultrasound, endoscopy, and the recurrent nerve
Noninvasive ventilation for pediatric patients under 1 year of age after cardiac surgery  Kazuo Chin, MD, PhD, Ken-ichi Takahashi, MD, Kazufumi Ohmori,
Neel R. Sodha, MD, Frank W. Sellke, MD 
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Right internal thoracic artery or saphenous vein grafting
Blood lactate level during extracorporeal life support as a surrogate marker for survival  Sung Jun Park, MD, Sang-pil Kim, MD, PhD, Joon Bum Kim, MD,
The Journal of Thoracic and Cardiovascular Surgery
How should we treat air leaks?
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Resuscitation practices in cardiac surgery
Cutoff for high-sensitivity cardiac troponin T is not arbitrary but according to usual clinical practice  Hector Cubero-Gallego, MD, PhD, Maria Heredia,
The lord of the rings  Antonio Miceli, MD, PhD 
In type A aortic dissection repair, an effective team approach and relational coordination are more important for patients' outcomes than surgeon volume 
Adenosine instead of supranormal potassium in cardioplegia: It is safe, efficient, and reduces the incidence of postoperative atrial fibrillation. A randomized.
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Rohit K. Singal, MD, MSc, FRCSC, Rakesh C. Arora, MD, PhD, FRCSC 
Benjamin G. Arenson, BSc, Lindsey A. MacDonald, BSc, Hilary P
Coronary arterial perfusion during venoarterial extracorporeal membrane oxygenation  Junji Kato, MD, Takahiko Seo, MD, PhD, Hisami Ando, MD, PhD, Hiroyuki.
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Fixing the supply problem
Clinical assessment of diastolic retrograde flow in the descending aorta for high-flow systemic-to-pulmonary artery shunting  Tomomi Hasegawa, MD, Yoshihiro.
Extracorporeal membrane oxygenation: The simplified weaning bridge
Michele Gallo, MD, Gino Gerosa, MD 
William T. Mahle, MD, Joseph M. Forbess, MD, Paul M
Stephen R. Broderick, MD, MPHS 
Yoan Lamarche, MD, Mahsa Elmi-Sarabi, MSc, Lillian Ding, MSc, James G
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc 
David L. Joyce, MD  The Journal of Thoracic and Cardiovascular Surgery 
Daniel T. Engelman, MD, FACS, Michael J. Germain, MD 
A fate worse than death  Jennifer S. Lawton, MD 
Hyperoxic ventilation exacerbates lung reperfusion injury
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Shunt right or left? Decision 2016
T. Brett Reece, MD  The Journal of Thoracic and Cardiovascular Surgery 
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
Postcardiotomy extracorporeal membrane oxygenation for refractory cardiogenic shock  Nilgun Bozbuga, MD, PhD  The Journal of Thoracic and Cardiovascular.
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
A call for standardized end point definitions regarding outcomes of extracorporeal membrane oxygenation  John J. Squiers, BSE, Brian Lima, MD, J. Michael.
The future of cardiac surgery training: A survival guide
Commentary: “Isn't cardiac surgery a team sport?”
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
First in line for robotic surgery: Would you want to know?
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
Apples remain apples NO matter what
A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.
Proactive or reactive? Best approach to limb ischemia in peripheral venoarterial extracorporeal life support  Matthew C. Black, MD, Mark S. Slaughter,
The evolution of cardiothoracic critical care
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Journal changes and initiatives
Akiko Tanaka, MD, PhD, Takeyoshi Ota, MD, PhD 
Presentation transcript:

Extracorporeal life support in patients with severe trauma: An advanced treatment strategy for refractory clinical settings  Massimo Bonacchi, MD, Rosario Spina, MD, Leonardo Torracchi, MD, Guy Harmelin, MD, Guido Sani, MD, Adriano Peris, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 6, Pages 1617-1626 (June 2013) DOI: 10.1016/j.jtcvs.2012.08.046 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Flow-chart of management of polytraumatized patients (reported as absolute number and %) and hospital sites of ECLS deployment. ED, Emergency department; ICU, intensive care unit; OR, operating room; ECLS, extracorporeal life support. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1617-1626DOI: (10.1016/j.jtcvs.2012.08.046) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Pre-ECLS parameters tested by ROC curves to recognize a cutoff value (criterion) corresponding to the highest Youden index for all significant different parameters between the ECLS failure and success groups. The sensitivity, specificity, and criterion are reported in boxes for all parameters tested. pH pre-ECLS value is the mean of at least 3 evaluations. BL, Blood lactate (the value represents the mean of the last 3 pre-ECLS start evaluations [mmol/L]); BT, bleeding time (before ECLS start [min]); BU, blood units (infused before ECLS start); CA, cardiac arrest (min); Hb, hemoglobin (the value represents the mean of the last 3 pre-ECLS start evaluations [g/dL]); IS, inotropic score (μg/kg/min); ISS, injury severity score. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1617-1626DOI: (10.1016/j.jtcvs.2012.08.046) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 ECLS success group. Arterial blood gas analysis parameters are shown from pre-ECLS to 12 hours left. The connection draws (with P value) were between pre-ECLS and the first significantly different value for any parameter. Values are expressed as mean ± standard deviation. pH pre-ECLS value is the mean of at least 3 evaluations. P value refers to the first statistically significant variation of each parameter from ECLS start. ECLS, Extracorporeal life support; Pco2, carbon dioxide tension (pre-ECLS value is the mean of at least 3 evaluations [mm Hg]); Po2/Fio2, oxygen tension/inspired oxygen fraction (pre-ECLS value is the mean of at least 3 evaluations). The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1617-1626DOI: (10.1016/j.jtcvs.2012.08.046) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 ECLS success group. Hemodynamic parameters are shown from pre-ECLS to 12 hours left. The connection draws (with P value) were between pre-ECLS and the first significant different value for any parameter. Values are expressed as mean ± standard deviation. P value refers to the first statistically significant variation of each parameter from ECLS start. BL, Blood lactate (pre-ECLS value is the mean of at least 3 evaluations [mmol/L]); ECLS, extracorporeal life support (pre-ECLS value is the mean of at least 3 evaluations); IS, inotropic score (pre-ECLS value is the mean of at least 3 evaluations [μg/kg/min]); MAP, mean arterial pressure (pre-ECLS value is the mean of at least 3 evaluations [mm Hg]). The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1617-1626DOI: (10.1016/j.jtcvs.2012.08.046) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions